Word

ENFORCER

Status

Registered

Status Code

700

Status Date

Tuesday, February 11, 2020

Serial Number

88461039

Registration Number

5981450

Registration Date

Tuesday, February 11, 2020

Mark Type

4000

Filing Date

Wednesday, June 5, 2019

Published for Opposition

Tuesday, November 26, 2019

Trademark Owner History

MorphoSys AG - Original Registrant

Classifications

5 Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; vaccine preparations; antibodies sold as an ingredient of pharmaceuticals for the treatment of treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the production of active ingredients of pharmaceuticals and vaccines; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis

42 Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; providing medical and scientific research information in the field of pharmaceuticals; Research and development services in the field of antibodies

Trademark Events

Feb 11, 2020

Registered-Principal Register

Nov 26, 2019

Official Gazette Publication Confirmation E-Mailed

Nov 26, 2019

Published For Opposition

Nov 6, 2019

Notification Of Notice Of Publication E-Mailed

Oct 17, 2019

Electronic Record Review Complete

Oct 11, 2019

On Hold - Electronic Record Review Required

Oct 7, 2019

Approved For Pub - Principal Register

Sep 13, 2019

Teas/Email Correspondence Entered

Sep 13, 2019

Correspondence Received In Law Office

Sep 10, 2019

Teas Response To Suspension Inquiry Received

Sep 3, 2019

Notification Of Letter Of Suspension E-Mailed

Sep 3, 2019

Letter Of Suspension E-Mailed

Sep 3, 2019

Suspension Letter Written

Aug 29, 2019

Teas/Email Correspondence Entered

Aug 29, 2019

Correspondence Received In Law Office

Aug 29, 2019

Assigned To Lie

Aug 26, 2019

Assigned To Examiner

Aug 21, 2019

Teas Voluntary Amendment Received

Jun 19, 2019

New Application Office Supplied Data Entered

Jun 8, 2019

New Application Entered